EZH2 expression correlates with locoregional recurrence after radiation in inflammatory breast cancer View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2014-12

AUTHORS

Bisrat G Debeb, Yun Gong, Rachel L Atkinson, Nour Sneige, Lei Huo, Ana Maria Gonzalez-Angulo, Mien-Chie Hung, Vicente Valero, Naoto T Ueno, Wendy A Woodward

ABSTRACT

BACKGROUND: Enhancer of zeste homolog 2 (EZH2), a member of the polycomb group proteins, has been shown to promote cancer progression and breast cancer stem cell (CSC) expansion. Breast CSCs are associated with resistance to radiation in inflammatory breast cancer (IBC), a rare but aggressive variant of breast cancer. In this retrospective study, we examined the clinical role of EZH2 in locoregional recurrence (LRR) of IBC patients treated with radiation. PATIENTS AND METHODS: 62 IBC patients who received radiation (7 pre-operative, 55 post-operative) and had adequate follow up to assess LRR were the subject of this study. Positive EZH2 status was defined as nuclear immunohistochemical staining in at least 10% of invasive cancer cells. Association of EZH2 expression with clinicopathologic features were evaluated using the Chi-square statistic and actuarial LRR free survival (LRFS) was determined using the Kaplan-Meier method. RESULTS: The median follow-up for this cohort was 33.7 months, and the 5-year overall LRFS rate was 69%. Of the 62 patients, 16 (25.8%) had LRR, and 15 out of 16 LRR occurred in EZH2 expressing cases. Univariate analysis indicated that patients who had EZH2-positive IBC had a significantly lower 5-year locoregional free survival (LRFS) rate than patients who had EZH2-negative IBC (93.3% vs. 59.1%; P = 0.01). Positive EZH2 expression was associated significantly with negative ER status (97.1% in ER- vs 48.1% in ER+; P < 0.0001) and triple-negative receptor status (P = 0.0001) and all triple-negative tumors were EZH2-positive. In multivariate analysis, only triple negative status remained an independent predictor of worse LRFS (hazard ratio 5.64, 95% CI 2.19 - 14.49, P < 0.0001). CONCLUSIONS: EZH2 correlates with locoregional recurrence in IBC patients who received radiation treatment. EZH2 expression status may be used in addition to receptor status to identify a subset of patients with IBC who recur locally in spite of radiation and may benefit from enrollment in clinical trials testing radiosensitizers. More... »

PAGES

58

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s13046-014-0058-9

DOI

http://dx.doi.org/10.1186/s13046-014-0058-9

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1000087704

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/25051981


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biomarkers, Tumor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chi-Square Distribution", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease-Free Survival", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Enhancer of Zeste Homolog 2 Protein", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunohistochemistry", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Inflammatory Breast Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kaplan-Meier Estimate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Multivariate Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Recurrence, Local", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Polycomb Repressive Complex 2", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Predictive Value of Tests", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Proportional Hazards Models", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Time Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Triple Negative Breast Neoplasms", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "The University of Texas MD Anderson Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA", 
            "Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Debeb", 
        "givenName": "Bisrat G", 
        "id": "sg:person.01255564307.72", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01255564307.72"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The University of Texas MD Anderson Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA", 
            "Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gong", 
        "givenName": "Yun", 
        "id": "sg:person.01104100260.94", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01104100260.94"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The University of Texas MD Anderson Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Clinical Cancer Prevention, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA", 
            "Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Atkinson", 
        "givenName": "Rachel L", 
        "id": "sg:person.01307651371.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01307651371.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The University of Texas MD Anderson Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sneige", 
        "givenName": "Nour", 
        "id": "sg:person.01357117667.72", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01357117667.72"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The University of Texas MD Anderson Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA", 
            "Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Huo", 
        "givenName": "Lei", 
        "id": "sg:person.010431453517.92", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010431453517.92"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The University of Texas MD Anderson Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gonzalez-Angulo", 
        "givenName": "Ana Maria", 
        "id": "sg:person.01066417500.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01066417500.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "China Medical University", 
          "id": "https://www.grid.ac/institutes/grid.254145.3", 
          "name": [
            "Department of Molecular and Cellular Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA", 
            "Center for Molecular Medicine and Graduate Institute of Cancer Biology, China Medical University, Taichung, Taiwan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hung", 
        "givenName": "Mien-Chie", 
        "id": "sg:person.01125127612.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01125127612.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The University of Texas MD Anderson Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA", 
            "Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Valero", 
        "givenName": "Vicente", 
        "id": "sg:person.014347536777.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014347536777.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The University of Texas MD Anderson Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA", 
            "Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ueno", 
        "givenName": "Naoto T", 
        "id": "sg:person.010304140203.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010304140203.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The University of Texas MD Anderson Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA", 
            "Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA", 
            "Division of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd., Unit 1202, 77030, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Woodward", 
        "givenName": "Wendy A", 
        "id": "sg:person.01340635437.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01340635437.54"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/nature07733", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000048827", 
          "https://doi.org/10.1038/nature07733"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nature07733", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000048827", 
          "https://doi.org/10.1038/nature07733"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1634/theoncologist.2011-0196", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002388480"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/jid.2011.11", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003383884", 
          "https://doi.org/10.1038/jid.2011.11"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/djn123", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003446650"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/neuonc/nos285", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003647398"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2009.09.052", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004692852"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.26179", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006149809"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1756-9966-32-70", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009206521", 
          "https://doi.org/10.1186/1756-9966-32-70"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ccr.2010.10.035", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009308257"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.cell.2008.12.043", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016572800"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/djj495", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017529958"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.25173", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023673889"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.25173", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023673889"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrc1991", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029188015", 
          "https://doi.org/10.1038/nrc1991"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrc1991", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029188015", 
          "https://doi.org/10.1038/nrc1991"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1245/s10434-011-1665-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030105498", 
          "https://doi.org/10.1245/s10434-011-1665-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1053/j.seminoncol.2007.11.009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034443745"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.0606599104", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038798177"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.clbc.2013.04.002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040007296"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nature05236", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041233330", 
          "https://doi.org/10.1038/nature05236"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nature05236", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041233330", 
          "https://doi.org/10.1038/nature05236"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nature05236", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041233330", 
          "https://doi.org/10.1038/nature05236"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.25180", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044645589"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.25180", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044645589"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1593/neo.05472", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050884001"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3892/ol.2012.696", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071525639"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.5966/sctm.2012-0036", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1073577316"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2014-12", 
    "datePublishedReg": "2014-12-01", 
    "description": "BACKGROUND: Enhancer of zeste homolog 2 (EZH2), a member of the polycomb group proteins, has been shown to promote cancer progression and breast cancer stem cell (CSC) expansion. Breast CSCs are associated with resistance to radiation in inflammatory breast cancer (IBC), a rare but aggressive variant of breast cancer. In this retrospective study, we examined the clinical role of EZH2 in locoregional recurrence (LRR) of IBC patients treated with radiation.\nPATIENTS AND METHODS: 62 IBC patients who received radiation (7 pre-operative, 55 post-operative) and had adequate follow up to assess LRR were the subject of this study. Positive EZH2 status was defined as nuclear immunohistochemical staining in at least 10% of invasive cancer cells. Association of EZH2 expression with clinicopathologic features were evaluated using the Chi-square statistic and actuarial LRR free survival (LRFS) was determined using the Kaplan-Meier method.\nRESULTS: The median follow-up for this cohort was 33.7 months, and the 5-year overall LRFS rate was 69%. Of the 62 patients, 16 (25.8%) had LRR, and 15 out of 16 LRR occurred in EZH2 expressing cases. Univariate analysis indicated that patients who had EZH2-positive IBC had a significantly lower 5-year locoregional free survival (LRFS) rate than patients who had EZH2-negative IBC (93.3% vs. 59.1%; P\u2009=\u20090.01). Positive EZH2 expression was associated significantly with negative ER status (97.1% in ER- vs 48.1% in ER+; P\u2009<\u20090.0001) and triple-negative receptor status (P = 0.0001) and all triple-negative tumors were EZH2-positive. In multivariate analysis, only triple negative status remained an independent predictor of worse LRFS (hazard ratio 5.64, 95% CI 2.19 - 14.49, P\u2009<\u20090.0001).\nCONCLUSIONS: EZH2 correlates with locoregional recurrence in IBC patients who received radiation treatment. EZH2 expression status may be used in addition to receptor status to identify a subset of patients with IBC who recur locally in spite of radiation and may benefit from enrollment in clinical trials testing radiosensitizers.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s13046-014-0058-9", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2480267", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.7822027", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2438826", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1094159", 
        "issn": [
          "0392-9078", 
          "1756-9966"
        ], 
        "name": "Journal of Experimental & Clinical Cancer Research", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "33"
      }
    ], 
    "name": "EZH2 expression correlates with locoregional recurrence after radiation in inflammatory breast cancer", 
    "pagination": "58", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "006ac6455700633de30b9687d115fcdfc703f89ba13c3c748f47b2e1fec266a0"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "25051981"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8308647"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s13046-014-0058-9"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1000087704"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s13046-014-0058-9", 
      "https://app.dimensions.ai/details/publication/pub.1000087704"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T13:10", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000367_0000000367/records_88247_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1186%2Fs13046-014-0058-9"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s13046-014-0058-9'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s13046-014-0058-9'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s13046-014-0058-9'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s13046-014-0058-9'


 

This table displays all metadata directly associated to this object as RDF triples.

303 TRIPLES      21 PREDICATES      72 URIs      42 LITERALS      30 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s13046-014-0058-9 schema:about N0f1576e6a6394292a81040c0c5e072a0
2 N0fd1b77888974d5eb87c91b02758dc0c
3 N0ffe7ab1f20b4fb79b478f52418bd81e
4 N17b854868718410291b41090efc2e08c
5 N21dc8cac6e674c62a3e7e79489a5d0db
6 N2712ae6d958a4204971df4edb73fd790
7 N438b20dbabd944e3a1a3e13c8a417baa
8 N438bd3425de8499bb4335f8d2d7cc04c
9 N43af10bc99ad46fdbf585f7cb90d8364
10 N5645220e888a4bdc89ffebb7f3adc352
11 N7a719da95ba94f0f81a5d14602f798e8
12 N83425bd812f24b82bc8fab3f833cbdf6
13 N8f3ca0c55bf74ae9a2f9038b32c6ff12
14 N92638505443a485dab72db7afaa28c51
15 Na1ba8378fe4f41b7970afcaa01b590f6
16 Nb846818d064847dfa5dab4bd761296ba
17 Nc901fb832c104f6283ebf64b33dd6e0f
18 Ne04c39ce02484727a1ea1d95a45c243d
19 Ne392fa02ef4c4f329dc9faeed973b67a
20 Neeec833c98b04dcf800d76737f70219d
21 Nef7d1f78faa6469ca6380778e166b962
22 anzsrc-for:11
23 anzsrc-for:1112
24 schema:author N2a844edb1716463c8915acf5060dce50
25 schema:citation sg:pub.10.1038/jid.2011.11
26 sg:pub.10.1038/nature05236
27 sg:pub.10.1038/nature07733
28 sg:pub.10.1038/nrc1991
29 sg:pub.10.1186/1756-9966-32-70
30 sg:pub.10.1245/s10434-011-1665-8
31 https://doi.org/10.1002/cncr.25173
32 https://doi.org/10.1002/cncr.25180
33 https://doi.org/10.1002/cncr.26179
34 https://doi.org/10.1016/j.ccr.2010.10.035
35 https://doi.org/10.1016/j.cell.2008.12.043
36 https://doi.org/10.1016/j.clbc.2013.04.002
37 https://doi.org/10.1016/j.ijrobp.2009.09.052
38 https://doi.org/10.1053/j.seminoncol.2007.11.009
39 https://doi.org/10.1073/pnas.0606599104
40 https://doi.org/10.1093/jnci/djj495
41 https://doi.org/10.1093/jnci/djn123
42 https://doi.org/10.1093/neuonc/nos285
43 https://doi.org/10.1593/neo.05472
44 https://doi.org/10.1634/theoncologist.2011-0196
45 https://doi.org/10.3892/ol.2012.696
46 https://doi.org/10.5966/sctm.2012-0036
47 schema:datePublished 2014-12
48 schema:datePublishedReg 2014-12-01
49 schema:description BACKGROUND: Enhancer of zeste homolog 2 (EZH2), a member of the polycomb group proteins, has been shown to promote cancer progression and breast cancer stem cell (CSC) expansion. Breast CSCs are associated with resistance to radiation in inflammatory breast cancer (IBC), a rare but aggressive variant of breast cancer. In this retrospective study, we examined the clinical role of EZH2 in locoregional recurrence (LRR) of IBC patients treated with radiation. PATIENTS AND METHODS: 62 IBC patients who received radiation (7 pre-operative, 55 post-operative) and had adequate follow up to assess LRR were the subject of this study. Positive EZH2 status was defined as nuclear immunohistochemical staining in at least 10% of invasive cancer cells. Association of EZH2 expression with clinicopathologic features were evaluated using the Chi-square statistic and actuarial LRR free survival (LRFS) was determined using the Kaplan-Meier method. RESULTS: The median follow-up for this cohort was 33.7 months, and the 5-year overall LRFS rate was 69%. Of the 62 patients, 16 (25.8%) had LRR, and 15 out of 16 LRR occurred in EZH2 expressing cases. Univariate analysis indicated that patients who had EZH2-positive IBC had a significantly lower 5-year locoregional free survival (LRFS) rate than patients who had EZH2-negative IBC (93.3% vs. 59.1%; P = 0.01). Positive EZH2 expression was associated significantly with negative ER status (97.1% in ER- vs 48.1% in ER+; P < 0.0001) and triple-negative receptor status (P = 0.0001) and all triple-negative tumors were EZH2-positive. In multivariate analysis, only triple negative status remained an independent predictor of worse LRFS (hazard ratio 5.64, 95% CI 2.19 - 14.49, P < 0.0001). CONCLUSIONS: EZH2 correlates with locoregional recurrence in IBC patients who received radiation treatment. EZH2 expression status may be used in addition to receptor status to identify a subset of patients with IBC who recur locally in spite of radiation and may benefit from enrollment in clinical trials testing radiosensitizers.
50 schema:genre research_article
51 schema:inLanguage en
52 schema:isAccessibleForFree true
53 schema:isPartOf Nb189694fb254485eaa6824cdd80c39d4
54 Nb545a7d9f4374d269641497b429f2342
55 sg:journal.1094159
56 schema:name EZH2 expression correlates with locoregional recurrence after radiation in inflammatory breast cancer
57 schema:pagination 58
58 schema:productId N3c9a69cc816d4532b176373f8426e6c9
59 N3eba0c89de3b4e5da7ebc224c1ac86bd
60 N5306d9c8919c49298bfe5950a9209e6a
61 N5bf0efad62f542a0b4e63a9e157f9184
62 Nb48d808eaf9b4c2a9f18c45a8e69be08
63 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000087704
64 https://doi.org/10.1186/s13046-014-0058-9
65 schema:sdDatePublished 2019-04-11T13:10
66 schema:sdLicense https://scigraph.springernature.com/explorer/license/
67 schema:sdPublisher Nadd111ddf93744a587870d34e86c5890
68 schema:url http://link.springer.com/10.1186%2Fs13046-014-0058-9
69 sgo:license sg:explorer/license/
70 sgo:sdDataset articles
71 rdf:type schema:ScholarlyArticle
72 N0cb5dcae29a7441587861acc0b009b9f rdf:first sg:person.01125127612.53
73 rdf:rest N4fd011ef1aa040a6949543627041b147
74 N0f1576e6a6394292a81040c0c5e072a0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
75 schema:name Humans
76 rdf:type schema:DefinedTerm
77 N0fd1b77888974d5eb87c91b02758dc0c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
78 schema:name Inflammatory Breast Neoplasms
79 rdf:type schema:DefinedTerm
80 N0ffe7ab1f20b4fb79b478f52418bd81e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
81 schema:name Time Factors
82 rdf:type schema:DefinedTerm
83 N17b854868718410291b41090efc2e08c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
84 schema:name Middle Aged
85 rdf:type schema:DefinedTerm
86 N1c2b66a45a7b4b43b8d7515e4da77c6c rdf:first sg:person.01066417500.42
87 rdf:rest N0cb5dcae29a7441587861acc0b009b9f
88 N21dc8cac6e674c62a3e7e79489a5d0db schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
89 schema:name Adult
90 rdf:type schema:DefinedTerm
91 N2712ae6d958a4204971df4edb73fd790 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Disease-Free Survival
93 rdf:type schema:DefinedTerm
94 N2a844edb1716463c8915acf5060dce50 rdf:first sg:person.01255564307.72
95 rdf:rest N582d285705814019bc9d49e23ff17f87
96 N3c9a69cc816d4532b176373f8426e6c9 schema:name readcube_id
97 schema:value 006ac6455700633de30b9687d115fcdfc703f89ba13c3c748f47b2e1fec266a0
98 rdf:type schema:PropertyValue
99 N3eba0c89de3b4e5da7ebc224c1ac86bd schema:name pubmed_id
100 schema:value 25051981
101 rdf:type schema:PropertyValue
102 N438b20dbabd944e3a1a3e13c8a417baa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Enhancer of Zeste Homolog 2 Protein
104 rdf:type schema:DefinedTerm
105 N438bd3425de8499bb4335f8d2d7cc04c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Immunohistochemistry
107 rdf:type schema:DefinedTerm
108 N43a568d86c7d4663aff2252c7b673f1f rdf:first sg:person.01307651371.05
109 rdf:rest Nd252e2fefe814c3d92695ccad48db1ca
110 N43af10bc99ad46fdbf585f7cb90d8364 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Multivariate Analysis
112 rdf:type schema:DefinedTerm
113 N44dfb604d1444e8580d0d54878b3d98c rdf:first sg:person.01340635437.54
114 rdf:rest rdf:nil
115 N4fd011ef1aa040a6949543627041b147 rdf:first sg:person.014347536777.33
116 rdf:rest N88789ef032a045debb332e9dc0870a70
117 N5306d9c8919c49298bfe5950a9209e6a schema:name nlm_unique_id
118 schema:value 8308647
119 rdf:type schema:PropertyValue
120 N5645220e888a4bdc89ffebb7f3adc352 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Proportional Hazards Models
122 rdf:type schema:DefinedTerm
123 N582d285705814019bc9d49e23ff17f87 rdf:first sg:person.01104100260.94
124 rdf:rest N43a568d86c7d4663aff2252c7b673f1f
125 N5bf0efad62f542a0b4e63a9e157f9184 schema:name dimensions_id
126 schema:value pub.1000087704
127 rdf:type schema:PropertyValue
128 N7a719da95ba94f0f81a5d14602f798e8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Chi-Square Distribution
130 rdf:type schema:DefinedTerm
131 N83425bd812f24b82bc8fab3f833cbdf6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Neoplasm Recurrence, Local
133 rdf:type schema:DefinedTerm
134 N88789ef032a045debb332e9dc0870a70 rdf:first sg:person.010304140203.24
135 rdf:rest N44dfb604d1444e8580d0d54878b3d98c
136 N8f3ca0c55bf74ae9a2f9038b32c6ff12 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Triple Negative Breast Neoplasms
138 rdf:type schema:DefinedTerm
139 N92638505443a485dab72db7afaa28c51 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Risk Factors
141 rdf:type schema:DefinedTerm
142 Na1ba8378fe4f41b7970afcaa01b590f6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Polycomb Repressive Complex 2
144 rdf:type schema:DefinedTerm
145 Na261f948c5bf411cbc25bcc3875b3531 rdf:first sg:person.010431453517.92
146 rdf:rest N1c2b66a45a7b4b43b8d7515e4da77c6c
147 Nadd111ddf93744a587870d34e86c5890 schema:name Springer Nature - SN SciGraph project
148 rdf:type schema:Organization
149 Nb189694fb254485eaa6824cdd80c39d4 schema:issueNumber 1
150 rdf:type schema:PublicationIssue
151 Nb48d808eaf9b4c2a9f18c45a8e69be08 schema:name doi
152 schema:value 10.1186/s13046-014-0058-9
153 rdf:type schema:PropertyValue
154 Nb545a7d9f4374d269641497b429f2342 schema:volumeNumber 33
155 rdf:type schema:PublicationVolume
156 Nb846818d064847dfa5dab4bd761296ba schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Treatment Outcome
158 rdf:type schema:DefinedTerm
159 Nc901fb832c104f6283ebf64b33dd6e0f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Female
161 rdf:type schema:DefinedTerm
162 Nd252e2fefe814c3d92695ccad48db1ca rdf:first sg:person.01357117667.72
163 rdf:rest Na261f948c5bf411cbc25bcc3875b3531
164 Ne04c39ce02484727a1ea1d95a45c243d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
165 schema:name Kaplan-Meier Estimate
166 rdf:type schema:DefinedTerm
167 Ne392fa02ef4c4f329dc9faeed973b67a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
168 schema:name Retrospective Studies
169 rdf:type schema:DefinedTerm
170 Neeec833c98b04dcf800d76737f70219d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
171 schema:name Biomarkers, Tumor
172 rdf:type schema:DefinedTerm
173 Nef7d1f78faa6469ca6380778e166b962 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Predictive Value of Tests
175 rdf:type schema:DefinedTerm
176 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
177 schema:name Medical and Health Sciences
178 rdf:type schema:DefinedTerm
179 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
180 schema:name Oncology and Carcinogenesis
181 rdf:type schema:DefinedTerm
182 sg:grant.2438826 http://pending.schema.org/fundedItem sg:pub.10.1186/s13046-014-0058-9
183 rdf:type schema:MonetaryGrant
184 sg:grant.2480267 http://pending.schema.org/fundedItem sg:pub.10.1186/s13046-014-0058-9
185 rdf:type schema:MonetaryGrant
186 sg:grant.7822027 http://pending.schema.org/fundedItem sg:pub.10.1186/s13046-014-0058-9
187 rdf:type schema:MonetaryGrant
188 sg:journal.1094159 schema:issn 0392-9078
189 1756-9966
190 schema:name Journal of Experimental & Clinical Cancer Research
191 rdf:type schema:Periodical
192 sg:person.010304140203.24 schema:affiliation https://www.grid.ac/institutes/grid.240145.6
193 schema:familyName Ueno
194 schema:givenName Naoto T
195 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010304140203.24
196 rdf:type schema:Person
197 sg:person.010431453517.92 schema:affiliation https://www.grid.ac/institutes/grid.240145.6
198 schema:familyName Huo
199 schema:givenName Lei
200 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010431453517.92
201 rdf:type schema:Person
202 sg:person.01066417500.42 schema:affiliation https://www.grid.ac/institutes/grid.240145.6
203 schema:familyName Gonzalez-Angulo
204 schema:givenName Ana Maria
205 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01066417500.42
206 rdf:type schema:Person
207 sg:person.01104100260.94 schema:affiliation https://www.grid.ac/institutes/grid.240145.6
208 schema:familyName Gong
209 schema:givenName Yun
210 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01104100260.94
211 rdf:type schema:Person
212 sg:person.01125127612.53 schema:affiliation https://www.grid.ac/institutes/grid.254145.3
213 schema:familyName Hung
214 schema:givenName Mien-Chie
215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01125127612.53
216 rdf:type schema:Person
217 sg:person.01255564307.72 schema:affiliation https://www.grid.ac/institutes/grid.240145.6
218 schema:familyName Debeb
219 schema:givenName Bisrat G
220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01255564307.72
221 rdf:type schema:Person
222 sg:person.01307651371.05 schema:affiliation https://www.grid.ac/institutes/grid.240145.6
223 schema:familyName Atkinson
224 schema:givenName Rachel L
225 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01307651371.05
226 rdf:type schema:Person
227 sg:person.01340635437.54 schema:affiliation https://www.grid.ac/institutes/grid.240145.6
228 schema:familyName Woodward
229 schema:givenName Wendy A
230 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01340635437.54
231 rdf:type schema:Person
232 sg:person.01357117667.72 schema:affiliation https://www.grid.ac/institutes/grid.240145.6
233 schema:familyName Sneige
234 schema:givenName Nour
235 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01357117667.72
236 rdf:type schema:Person
237 sg:person.014347536777.33 schema:affiliation https://www.grid.ac/institutes/grid.240145.6
238 schema:familyName Valero
239 schema:givenName Vicente
240 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014347536777.33
241 rdf:type schema:Person
242 sg:pub.10.1038/jid.2011.11 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003383884
243 https://doi.org/10.1038/jid.2011.11
244 rdf:type schema:CreativeWork
245 sg:pub.10.1038/nature05236 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041233330
246 https://doi.org/10.1038/nature05236
247 rdf:type schema:CreativeWork
248 sg:pub.10.1038/nature07733 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000048827
249 https://doi.org/10.1038/nature07733
250 rdf:type schema:CreativeWork
251 sg:pub.10.1038/nrc1991 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029188015
252 https://doi.org/10.1038/nrc1991
253 rdf:type schema:CreativeWork
254 sg:pub.10.1186/1756-9966-32-70 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009206521
255 https://doi.org/10.1186/1756-9966-32-70
256 rdf:type schema:CreativeWork
257 sg:pub.10.1245/s10434-011-1665-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030105498
258 https://doi.org/10.1245/s10434-011-1665-8
259 rdf:type schema:CreativeWork
260 https://doi.org/10.1002/cncr.25173 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023673889
261 rdf:type schema:CreativeWork
262 https://doi.org/10.1002/cncr.25180 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044645589
263 rdf:type schema:CreativeWork
264 https://doi.org/10.1002/cncr.26179 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006149809
265 rdf:type schema:CreativeWork
266 https://doi.org/10.1016/j.ccr.2010.10.035 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009308257
267 rdf:type schema:CreativeWork
268 https://doi.org/10.1016/j.cell.2008.12.043 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016572800
269 rdf:type schema:CreativeWork
270 https://doi.org/10.1016/j.clbc.2013.04.002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040007296
271 rdf:type schema:CreativeWork
272 https://doi.org/10.1016/j.ijrobp.2009.09.052 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004692852
273 rdf:type schema:CreativeWork
274 https://doi.org/10.1053/j.seminoncol.2007.11.009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034443745
275 rdf:type schema:CreativeWork
276 https://doi.org/10.1073/pnas.0606599104 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038798177
277 rdf:type schema:CreativeWork
278 https://doi.org/10.1093/jnci/djj495 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017529958
279 rdf:type schema:CreativeWork
280 https://doi.org/10.1093/jnci/djn123 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003446650
281 rdf:type schema:CreativeWork
282 https://doi.org/10.1093/neuonc/nos285 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003647398
283 rdf:type schema:CreativeWork
284 https://doi.org/10.1593/neo.05472 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050884001
285 rdf:type schema:CreativeWork
286 https://doi.org/10.1634/theoncologist.2011-0196 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002388480
287 rdf:type schema:CreativeWork
288 https://doi.org/10.3892/ol.2012.696 schema:sameAs https://app.dimensions.ai/details/publication/pub.1071525639
289 rdf:type schema:CreativeWork
290 https://doi.org/10.5966/sctm.2012-0036 schema:sameAs https://app.dimensions.ai/details/publication/pub.1073577316
291 rdf:type schema:CreativeWork
292 https://www.grid.ac/institutes/grid.240145.6 schema:alternateName The University of Texas MD Anderson Cancer Center
293 schema:name Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
294 Department of Clinical Cancer Prevention, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
295 Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
296 Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
297 Division of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd., Unit 1202, 77030, Houston, TX, USA
298 Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
299 rdf:type schema:Organization
300 https://www.grid.ac/institutes/grid.254145.3 schema:alternateName China Medical University
301 schema:name Center for Molecular Medicine and Graduate Institute of Cancer Biology, China Medical University, Taichung, Taiwan
302 Department of Molecular and Cellular Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
303 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...